Boyer & Corporon Wealth Management, LLC Acelrx Pharmaceuticals Inc Transaction History

Boyer & Corporon Wealth Management, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 13, 2019	SELL	$2.1 - $2.87 $73,710 - $100,737	-35,100 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.13 - $4.8 $74,763 - $168,480	35,100 New	35,100 $811,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Boyer & Corporon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boyer & Corporon Wealth Management, LLC with notifications on news.